2010•Chinese Journal of New Drugs and Clinical RemediesRequires access
Use of regadenoson,a new adenosine A_(2A) receptor agonist,in myocardial perfusion imaging
Zhenhua Huang
Open publisher page 0 citations
Abstract
Myocardial perfusion imaging plays very important role in detecting coronary artery disease,assessing risk,detecting viable myocardium,evaluating the effects of therapeutic interventions.Regadenoson is a new adenosine A2A receptor agonist.Compared with adenosine,a typical drug used for myocardial perfusion imaging,regadenoson does not cause bronchial constriction and atrial-ventricular block.It has the advantage of good efficacy and less side effects.